ZA200703695B - Treatment of mastitis with enrofloxacin - Google Patents

Treatment of mastitis with enrofloxacin

Info

Publication number
ZA200703695B
ZA200703695B ZA200703695A ZA200703695A ZA200703695B ZA 200703695 B ZA200703695 B ZA 200703695B ZA 200703695 A ZA200703695 A ZA 200703695A ZA 200703695 A ZA200703695 A ZA 200703695A ZA 200703695 B ZA200703695 B ZA 200703695B
Authority
ZA
South Africa
Prior art keywords
enrofloxacin
mastitis
treatment
Prior art date
Application number
ZA200703695A
Other languages
English (en)
Inventor
Pirro Franz
Fraatz Kristine
Froyman Robrecht
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35462240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200703695(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of ZA200703695B publication Critical patent/ZA200703695B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ZA200703695A 2004-11-12 2007-05-08 Treatment of mastitis with enrofloxacin ZA200703695B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004054873A DE102004054873A1 (de) 2004-11-12 2004-11-12 Behandlung von Mastitis

Publications (1)

Publication Number Publication Date
ZA200703695B true ZA200703695B (en) 2008-08-27

Family

ID=35462240

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703695A ZA200703695B (en) 2004-11-12 2007-05-08 Treatment of mastitis with enrofloxacin

Country Status (27)

Country Link
US (2) US20070265275A1 (da)
EP (1) EP1812002B1 (da)
JP (2) JP2008519781A (da)
KR (1) KR20070084182A (da)
CN (1) CN101056638A (da)
AR (1) AR051763A1 (da)
AT (1) ATE526970T1 (da)
BR (1) BRPI0517473A (da)
CA (1) CA2587187A1 (da)
CR (1) CR9109A (da)
DE (2) DE102004054873A1 (da)
DK (1) DK1812002T3 (da)
ES (1) ES2373449T3 (da)
HR (1) HRP20120002T1 (da)
IL (1) IL182993A (da)
MX (1) MX2007005526A (da)
NO (1) NO20072890L (da)
NZ (1) NZ555062A (da)
PE (1) PE20061139A1 (da)
PL (1) PL1812002T3 (da)
PT (1) PT1812002E (da)
RU (1) RU2413514C2 (da)
SI (1) SI1812002T1 (da)
SV (1) SV2006002296A (da)
UA (1) UA92593C2 (da)
WO (1) WO2006050826A2 (da)
ZA (1) ZA200703695B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5217276B2 (ja) * 2007-07-19 2013-06-19 ニプロ株式会社 注射用抗菌剤の製造方法
GB2480276A (en) * 2010-05-11 2011-11-16 Michael Hilary Burke Process for the preparation of an aqueous injectable enrofloxacin antimicrobial formulation
CN101933927A (zh) * 2010-06-30 2011-01-05 洛阳惠中兽药有限公司 一种含恩诺沙星六水合物组合物及其在制备治疗或预防家畜疾病的药物中的应用
NZ702087A (en) * 2012-06-29 2016-12-23 Bayer Animal Health Gmbh Pharmaceutical compositions and treatment of mastitis
UA119642C2 (uk) * 2013-03-15 2019-07-25 Меріал, Інк. Протимікробні поліамідні композиції та лікування маститу
RU2655772C1 (ru) * 2016-12-26 2018-05-29 Федеральное государственное бюджетное научное учреждение "Курский научно-исследовательский институт агропромышленного производства" Йодсодержащий состав для лечения мастита у коров
RU2652354C1 (ru) * 2017-11-07 2018-04-25 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный аграрный университет" (ФГБОУ ВО Волгоградский ГАУ) Способ терапии коров, больных маститом
CN108051512A (zh) * 2017-11-27 2018-05-18 佛山科学技术学院 一种牛乳中氟喹诺酮类药物残留量的检测方法
CN110812326B (zh) * 2019-11-04 2022-04-22 黑龙江省农业科学院畜牧兽医分院 一种辛伐他汀混悬乳剂及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
CA2176298C (en) 1995-06-27 2009-01-27 Dennis D. Copeland A single high dose fluoroquinolone treatment

Also Published As

Publication number Publication date
JP2013063985A (ja) 2013-04-11
KR20070084182A (ko) 2007-08-24
CR9109A (es) 2007-10-04
PE20061139A1 (es) 2006-12-29
BRPI0517473A (pt) 2008-10-07
IL182993A0 (en) 2007-09-20
RU2413514C2 (ru) 2011-03-10
ATE526970T1 (de) 2011-10-15
AR051763A1 (es) 2007-02-07
RU2007121516A (ru) 2008-12-20
WO2006050826A2 (de) 2006-05-18
NZ555062A (en) 2009-12-24
UA92593C2 (ru) 2010-11-25
NO20072890L (no) 2007-06-06
MX2007005526A (es) 2007-07-09
CN101056638A (zh) 2007-10-17
WO2006050826A3 (de) 2006-07-27
EP1812002B1 (de) 2011-10-05
PT1812002E (pt) 2011-12-30
JP2008519781A (ja) 2008-06-12
EP1812002A2 (de) 2007-08-01
SI1812002T1 (sl) 2012-03-30
DE202005022066U1 (de) 2012-12-06
DE102004054873A1 (de) 2006-05-18
IL182993A (en) 2013-03-24
US20130023540A1 (en) 2013-01-24
CA2587187A1 (en) 2006-05-18
HRP20120002T1 (hr) 2012-02-29
US20070265275A1 (en) 2007-11-15
SV2006002296A (es) 2006-06-26
PL1812002T3 (pl) 2012-03-30
DK1812002T3 (da) 2012-02-06
ES2373449T3 (es) 2012-02-03

Similar Documents

Publication Publication Date Title
ZA200700420B (en) Methods of treatment of endobronchial infections
ZA200703695B (en) Treatment of mastitis with enrofloxacin
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
IL185757A0 (en) Methods of decreasing calcifcation
IL186408A0 (en) Combination treatment methods
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
GB0605715D0 (en) Treatment of laminitis
GB2430002B (en) Well treatment
EP1890761A4 (en) PROCESS FOR REINFORCING LIPOLYSIS
GB0511769D0 (en) Treatment
GB0400976D0 (en) Methods of diagnosis
EP1793813A4 (en) TREATMENT OF HYPERACTIVITY DISORDER WITH DEFICIT ATTENTION (ADHD)
GB0426196D0 (en) Methods of treatment
GB0426141D0 (en) Treatment
GB0424085D0 (en) Well treatment
GB0419199D0 (en) Methods of diagnosis
GB0408521D0 (en) Treatment of sepsis
PL1934388T3 (pl) Sposób projektowania leków
GB0420873D0 (en) Methods of diagnosis
GB0422012D0 (en) Methods of treatment
HU0400952D0 (en) Treatment of anus-cancer
GB0518003D0 (en) Treatment of hepatatis c
AU2004907262A0 (en) Methods of treatment
AU2004907263A0 (en) Methods of treatment
GB0418393D0 (en) Treatment of cachexia